Advanced-glycation-end-product-induced formation of immunoproteasomes: involvement of RAGE and Jak2/STAT1

Related Experiment Video

Updated: May 19, 2026

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

Stefanie Grimm1, Christiane Ott, Melanie Hörlacher

  • 1Institute of Nutrition, Friedrich Schiller University Jena, 07743 Jena, Germany.

The Biochemical Journal
|August 16, 2012
PubMed

Insights

Advanced glycation-end products (AGEs) activate the immunoproteasome via the RAGE-Jak2-STAT1 pathway. This discovery sheds light on immune responses in aging and diseases like Alzheimer's and diabetes.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cellular Aging

Background:

  • Advanced glycation-end products (AGEs) accumulate with aging and in diseases like Alzheimer's and diabetes.
  • AGEs are implicated in inhibiting proteolytic pathways and activating immune responses.

Purpose of the Study:

  • To investigate the molecular mechanisms by which AGEs induce immunoproteasome expression.
  • To elucidate the role of the Jak2/STAT1 pathway and RAGE in AGE-mediated immunoproteasome regulation.

Main Methods:

  • Investigated AGE-induced expression of immunoproteasomal subunits.
  • Analyzed the activation of the Jak2/STAT1 signaling pathway.
  • Utilized Jak2 inhibition (AG-490) and STAT1 silencing (siRNA).
  • Examined the role of the Receptor for AGEs (RAGE) through gene silencing.

Main Results:

  • AGEs were shown to induce the expression of immunoproteasomal subunits.
  • Activation of the Jak2/STAT1 signaling pathway was demonstrated.
  • Inhibition of Jak2 or STAT1 abolished AGE-induced immunoproteasome expression.
  • AGE-induced immunoproteasome up-regulation was confirmed to be RAGE-mediated.

Conclusions:

  • The study identifies a novel signaling pathway involving RAGE, Jak2, and STAT1 in AGE-induced immunoproteasome expression.
  • This pathway is crucial for regulating immune responses associated with AGE accumulation.
  • Findings provide insights into the molecular basis of AGEs' role in aging and related pathologies.

More Related Videos

Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice06:40

Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice

Published on: February 9, 2014

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...